BHLHE40 and osteoporosis: Finally, we established a mouse model of estrogen-deficient and senile osteoporosis and found a significant improvement in abnormal bone resorption in Bhlhe40-deficient mice, suggesting that Bhlhe40 is an effective target for the treatment of osteoporosis.